Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2002;22:901-906
Published online before print April 25, 2002, doi: 10.1161/01.ATV.0000020006.89055.11
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
22/6/901    most recent
01.ATV.0000020006.89055.11v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Spyridopoulos, I.
Right arrow Articles by Losordo, D. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Spyridopoulos, I.
Right arrow Articles by Losordo, D. W.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*NITRIC OXIDE
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2002;22:901.)
© 2002 American Heart Association, Inc.


Vascular Biology

Divergence of Angiogenic and Vascular Permeability Signaling by VEGF

Inhibition of Protein Kinase C Suppresses VEGF-Induced Angiogenesis, but Promotes VEGF-Induced, NO-Dependent Vascular Permeability

Ioakim Spyridopoulos; Corinne Luedemann; Donghui Chen; Marianne Kearney; Dongfen Chen; Toyoaki Murohara; Nicole Principe; Jeffrey M. Isner; Douglas W. Losordo

From the Department of Cardiovascular Research, St. Elizabeth’s Medical Center, Boston, Mass.

Correspondence to Douglas W. Losordo, MD, Department of Cardiovascular Research, St. Elizabeth’s Medical Center, 736 Cambridge St, Boston, MA 02135. E-mail douglas.losordo{at}tufts.edu

Abstract Vascular endothelial growth factor (VEGF) promotes angiogenesis by a variety of mechanisms including stimulation of endothelial cell proliferation and migration and increasing vascular permeability. Although its mitogenic activity is mediated primarily by the ß2-isoforms of protein kinase C (PKC), little is known about the signaling pathways transducing its other physiological properties. Accordingly, we used a novel inhibitor molecule to examine the role of PKC isoforms {alpha} and ß in mediating VEGF-induced angiogenesis and vascular permeability. Because conventional inhibitors of PKC, such as staurosporine or calphostin C, also inhibit a variety of other protein kinases, we used a novel compound to specifically inhibit PKC. A myristoylated peptide, which mimics the pseudosubstrate motif of PKC-{alpha} and -ß subtypes, has been shown to be a highly selective and cell-permeable inhibitor of PKC. Blocking led, as expected, to abrogation of VEGF-induced endothelial cell proliferation in vitro. In vivo, VEGF-induced angiogenesis was impaired by myristoylated peptide. Surprisingly, selective inhibition of PKC induced vascular permeability in vivo via a NO-dependent mechanism. Moreover, PKC inhibition led to a 6.4-fold induction of NO synthase (NOS) activity in endothelial cells. Our findings demonstrate that activation of PKC is a major signaling pathway required for VEGF-induced proliferation and angiogenesis, whereas vascular permeability was enhanced by blocking PKC. Inhibition of calcium-dependent PKC by itself led to induction of NOS. Although NOS is a downstream target for VEGF-induced angiogenesis, its induction by PKC inhibition was not sufficient to promote neovascularization. These results reveal that angiogenesis and vascular permeability induced by VEGF are mediated by mechanisms which ultimately diverge.


Key Words: vascular endothelial growth factor • programmed cell death • angiogenesis • protein kinase C inhibitor • vascular permeability • nitric oxide




This article has been cited by other articles:


Home page
Circ. Res.Home page
D. Serban, J. Leng, and D. Cheresh
H-Ras Regulates Angiogenesis and Vascular Permeability by Activation of Distinct Downstream Effectors
Circ. Res., June 6, 2008; 102(11): 1350 - 1358.
[Abstract] [Full Text] [PDF]


Home page
Jpn J Clin OncolHome page
Y. Komi, O. Ohno, Y. Suzuki, M. Shimamura, K. Shimokado, K. Umezawa, and S. Kojima
Inhibition of Tumor Angiogenesis by Targeting Endothelial Surface ATP Synthase with Sangivamycin
Jpn. J. Clin. Oncol., November 1, 2007; 37(11): 867 - 873.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
Z.-Y. Chen, G.-G. Feng, K. Nishiwaki, Y. Shimada, Y. Fujiwara, T. Komatsu, and N. Ishikawa
Possible roles of neuropeptide Y Y3-receptor subtype in rat aortic endothelial cell proliferation under hypoxia, and its specific signal transduction
Am J Physiol Heart Circ Physiol, August 1, 2007; 293(2): H959 - H967.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
E. R. Jacobs, D. Zhu, S. Gruenloh, B. Lopez, and M. Medhora
VEGF-induced relaxation of pulmonary arteries is mediated by endothelial cytochrome P-450 hydroxylase
Am J Physiol Lung Cell Mol Physiol, September 1, 2006; 291(3): L369 - L377.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. Lee, M. Aoki, T. Kondo, K. Kobayashi, K. Okumura, K. Komori, and T. Murohara
Therapeutic Angiogenesis With Intramuscular Injection of Low-Dose Recombinant Granulocyte-Colony Stimulating Factor
Arterioscler Thromb Vasc Biol, December 1, 2005; 25(12): 2535 - 2541.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
S. H. Rudolfsson, P. Wikstrom, A. Jonsson, O. Collin, and A. Bergh
Hormonal Regulation and Functional Role of Vascular Endothelial Growth Factor A in the Rat Testis
Biol Reprod, February 1, 2004; 70(2): 340 - 347.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. M. Tickerhoof, P A. Farrell, and D. H. Korzick
Alterations in rat coronary vasoreactivity and vascular protein kinase C isoforms in Type 1 diabetes
Am J Physiol Heart Circ Physiol, December 1, 2003; 285(6): H2694 - H2703.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
H. Matsuno, A. Ishisaki, K. Nakajima, K. Okada, S. Ueshima, O. Matsuo, and O. Kozawa
Lack of {alpha}2-antiplasmin promotes re-endothelialization via over-release of VEGF after vascular injury in mice
Blood, November 15, 2003; 102(10): 3621 - 3628.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. Yamada, S. Kim, K. Egashira, M. Takeya, T. Ikeda, O. Mimura, and H. Iwao
Molecular Mechanism and Role of Endothelial Monocyte Chemoattractant Protein-1 Induction by Vascular Endothelial Growth Factor
Arterioscler Thromb Vasc Biol, November 1, 2003; 23(11): 1996 - 2001.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. Eriksson, R. Cao, J. Roy, K. Tritsaris, C. Wahlestedt, S. Dissing, J. Thyberg, and Y. Cao
Small GTP-Binding Protein Rac Is an Essential Mediator of Vascular Endothelial Growth Factor-Induced Endothelial Fenestrations and Vascular Permeability
Circulation, March 25, 2003; 107(11): 1532 - 1538.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. W. Breslin, P. J. Pappas, J. J. Cerveira, R. W. Hobson II, and W. N. Duran
VEGF increases endothelial permeability by separate signaling pathways involving ERK-1/2 and nitric oxide
Am J Physiol Heart Circ Physiol, January 1, 2003; 284(1): H92 - H100.
[Abstract] [Full Text] [PDF]